Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
3,876 articles
Drägerwerk AG & Co. KGaA Q4 Earnings Call Highlights
Drägerwerk AG & Co. KGaA (ETR:DRW3) reported record net sales and sharply higher earnings for fiscal 2025, with management pointing to...
Litchfield Hills Research Comments on Star Equity Q1 Earnings
Star Equity Holdings, Inc. (NASDAQ:STRR – Free Report) – Research analysts at Litchfield Hills Research issued their Q1 2026 earnings per...
Reviewing Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Sensus Healthcare (NASDAQ:SRTS)
Sensus Healthcare (NASDAQ:SRTS – Get Free Report) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Free Report) are both...
Novo Chairman Faces Testy Investors With Little Progress So Far
Novo Nordisk A/S’s Chairman Lars Rebien Sorensen will face investors at the company’s annual meeting for the first time on Thursday after his...
Super Micro Computer Hit With Securities Fraud Lawsuit Amid Alleged China Sales Cover-Up And Nvidia Chip Smuggling Scandal
Super Micro Computer (NASDAQ:SMCI) is facing a class-action lawsuit. The server maker is accused of misleading investors about exposure to China and...
Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares
On Wednesday, Cathie Wood-led Ark Invest made significant trades, notably involving Tempus AI Inc (NASDAQ:TEM) and Meta Platforms...
📰
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO
NEW ORLEANS, March 25, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 5,...
Jack Dorsey Once Revealed He Sounded 'Gibberish' As A Child — The Twitter Founder Did This After Realizing He Couldn't 'Function' Like That
Jack Dorsey once revealed that early struggles with speech and shyness pushed him to deliberately pursue—and try to master—the art of...
Urban-gro, DraftKings, Sarepta Therapeutics, Destiny Tech100 And AMD: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks closed higher on Wednesday, with the Dow Jones Industrial Average up 0.66% at 46,429.49, the S&P 500 gaining 0.5% to 6,591.90 and the...
📰
Surging Oil Prices Spark Market Jitters
The Motley Fool's Hidden Gems team discusses some historical disruptions in the energy market, how trends in semiconductors are reshaping the S&P...
📰
Surging Oil Prices Spark Market Jitters
The Motley Fool's Hidden Gems team discusses some historical disruptions in the energy market, how trends in semiconductors are reshaping the S&P...
📰
Surging Oil Prices Spark Market Jitters
The Motley Fool's Hidden Gems team discusses some historical disruptions in the energy market, how trends in semiconductors are reshaping the S&P...
📰
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results
TORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB:MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the...
📰
Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates
ROCKVILLE, Md. and SUZHOU, China, March 25, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX:...
📰
Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<ul...
📰
POMDOCTOR CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against PomDoctor, Ltd. and Encourages Stockholders to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PomDoctor (POM) To Contact Him Directly...
📰
AtlanTech Vision Files Provisional Patent for PVD™ HemiComb™ - Minimalist Glasses-Free Light-Field Displays
AtlanTech Vision Corporation (ATVICO) today announced the successful filing of a U.S. Provisional Patent Application for its groundbreaking PVD™...
📰
Palvella Stock Up 340% as Insider Sells Shares. Here's What the Move Does (And Does Not) Signal
This clinical-stage biotech advancing therapies for rare skin diseases reported a notable insider sale amid a year of sharp stock gains.
📰
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
Draganfly Stock Sheds 21% Post-Earnings — Here's Why It's Still A Buy
Shares of drone tech company Draganfly Inc. (NASDAQ:DPRO) sold off hard on Wednesday after disappointing fourth-quarter earnings — but the report and...
📰
MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Why Medpace (MEDP) Outpaced the Stock Market Today
In the closing of the recent trading day, Medpace (MEDP) stood at $466.8, denoting a +1.32% move from the preceding trading day.
📰
ROSEN, HIGHLY REGARDED INVESTOR RIGHTS COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inovio (INO) To Contact Him Directly To...
📰
Dyadic (DYAI) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, March 25, 2026 at 5 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰
Oscar Health, Inc. (OSCR) Outpaces Stock Market Gains: What You Should Know
Oscar Health, Inc. (OSCR) concluded the recent trading session at $12.21, signifying a +1.5% move from its prior day's close.
📰
Is Pfizer Stock a Buy After This Win?
Good news has been scarce for this beaten-down drugmaker.
📰
Vertex Pharmaceuticals (VRTX) Laps the Stock Market: Here's Why
Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $454.97, signifying a +1.42% move from its prior day's close.
📰
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know
In the most recent trading session, Amgen (AMGN) closed at $353.93, indicating a +1.58% shift from the previous trading day.
📰
Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $47.09, moving +1.42% from the previous trading session.
📰
Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade
Adma Biologics (ADMA) closed the most recent trading day at $9.63, moving 15% from the previous trading session.
📰
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know
The latest trading day saw Eli Lilly (LLY) settling at $916.31, representing a +1.47% change from its previous close.
📰
Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing
Johnson & Johnson (JNJ) closed the most recent trading day at $239.93, moving +1.98% from the previous trading session.
📰
Bristol Myers Squibb (BMY) Surpasses Market Returns: Some Facts Worth Knowing
In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $58.94, denoting a +2.7% move from the preceding trading day.
📰
Novo Nordisk (NVO) Stock Slides as Market Rises: Facts to Know Before You Trade
Novo Nordisk (NVO) closed the most recent trading day at $36.33, moving 1.52% from the previous trading session.